An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast-ovarian cancer syndrome

首页> 外文期刊>Progress in Artificial Intelligence >An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast-ovarian cancer syndrome

【24h】

An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast-ovarian cancer syndrome

机译：在遗传性乳腺卵巢癌症综合征中对奥拉帕里布的复发和难治性BRCA2突变的非小细胞肺癌的特殊反应

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Progress in Artificial Intelligence》 |2020年第1期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类计算技术、计算机技术;
关键词

相似文献

外文文献
中文文献
专利

1. An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast-ovarian cancer syndrome [J] . Progress in Artificial Intelligence . 2020,第1期

机译：在遗传性乳腺卵巢癌症综合征中对奥拉帕里布的复发和难治性BRCA2突变的非小细胞肺癌的特殊反应
2. Monotherapy Administration of Sorafenib in Patients With Non-Small Cell Lung Cancer (MISSION) Trial A Phase III, Multicenter, Placebo-Controlled Trial of Sorafenib in Patients with Relapsed or Refractory Predominantly Nonsquamous Non-Small-Cell Lung Cancer after 2 or 3 Previous Treatment Regimens [J] . Paz-Ares Luis, Hirsh Vera, Zhang Li, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2015,第12期

机译：索拉非尼单药治疗非小细胞肺癌（MISSION）试验A阶段Sorafenib在经过2或3次既往治疗或复发或难治性非鳞状非小细胞肺癌患者中的III期，多中心，安慰剂对照试验方案
3. Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer [J] . Kaichao Feng, Yelei Guo, Hanren Dai, Science China Life Sciences . 2016,第5期

机译：嵌合抗原受体修饰的T细胞用于表皮生长因子受体表达的晚期复发/难治性非小细胞肺癌患者的免疫治疗
4. A proteomic signature of relapse-related death predicting clinical outcome in human non-small cell lung cancer [C] . Kiyoshi Yanagisawa M.D., Shuta Tomida, Yukako Shimada, ASMS Conference on Mass Spectrometry and Allied Topics . 2006

机译：复发相关死亡的蛋白质组学特征预测人非小细胞肺癌临床结果
5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
6. Somatic BRCA2 Mutation-Positive Concurrent Accessory Male Breast Cancer (BC) and Non-Small Cell Lung Cancer (NSCLC): Excellent Efficacy of Palbociclib Fulvestrant and Leuprolide in Platinum-Exposed and Endocrine-Refractory BC Associated with Cyclin D1 and FGFR1 Amplification and of Carboplatin Paclitaxel and Radiation in NSCLC [O] . Yu Cheng, Ningjing Li, Ann Eapen, 2019

机译：体细胞BRCA2突变阳性同时发生的男性辅助性乳腺癌（BC）和非小细胞肺癌（NSCLC）：Palbociclib氟维西汀和亮丙瑞林在铂暴露和内分泌难治性BC中与细胞周期蛋白D1和FGFR1扩增相关的极佳功效非小细胞肺癌中的卡铂紫杉醇和放射
7. Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer [O] . Kaichao Feng, Yelei Guo, Hanren Dai, 2016

机译：嵌合抗原受体修饰的T细胞用于表皮生长因子受体表达的晚期复发/难治性非小细胞肺癌患者的免疫治疗

An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast-ovarian cancer syndrome

著录项

相似文献

相关主题

期刊订阅